KLOX Technologies Inc.   Report issue

For profit
Founded: Laval QC Canada (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2017
NCT03271164
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

KLOX Technologies Inc.

Active Ingredients

Drugs in Other Trials (1)

vitamin e (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1